Endophthalmitis Vitrectomy Study (EVS)
NCT00000130 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2009-09-17
Summary
To determine the role of initial pars plana vitrectomy in the management of postoperative bacterial endophthalmitis.
To determine the role of intravenous antibiotics in the management of bacterial endophthalmitis.
To determine which factors, other than treatment, predict outcome in postoperative bacterial endophthalmitis.
Conditions
- Endophthalmitis
- Eye Infections
Interventions
- DRUG
-
Intravitreal Antibiotics
- PROCEDURE
-
Initial Pars Plana Vitrectomy
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1990-02-28
- Completion
- 1995-01-31
More Related Trials
-
Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis
NCT01760746 ·Status: COMPLETED
-
Ocular Discomfort Assessment After Intravitreal Injections
NCT02806830 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
NCT01996826 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration
NCT00503022 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy
NCT00596505 ·Status: COMPLETED
-
Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
NCT01072357 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
NCT01854593 ·Status: COMPLETED ·Phase: PHASE4
-
Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
NCT01860586 ·Status: COMPLETED ·Phase: NA
-
The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram
NCT00478530 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma
NCT02901236 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NCT01256580 ·Status: WITHDRAWN ·Phase: NA
-
Optic Nerve and Retinal Functions With Bevacizumab
NCT01361828 ·Status: COMPLETED
-
Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea
NCT01501760 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery
NCT02767219 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Avastin for Treatment of Corneal Neovascularization
NCT00559936 ·Status: COMPLETED ·Phase: PHASE1
-
IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes
NCT06559488 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab for the Treatment of Corneal Neovascularization
NCT00992849 ·Status: UNKNOWN ·Phase: PHASE2
-
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
NCT02367365 ·Status: COMPLETED
-
Endophthalmitis Post Intravitreal Injections
NCT04035369 ·Status: UNKNOWN ·Phase: NA
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
NCT00336323 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
NCT00556348 ·Status: COMPLETED ·Phase: PHASE4
-
Single or Combined Protocols for NV-AMD
NCT03552770 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization
NCT06243406 ·Status: NOT_YET_RECRUITING